Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Evaluate the Safety and Preliminary Efficacy of Subretinal Administration of JWK001 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

NCT07776522 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07776522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07776522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Evaluate the Safety and Preliminary Efficacy of Subretinal Administration of JWK001 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
August 31, 2026
Completion date
January 14, 2032
Enrollment
50 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration (namd) wet amd